The authors found that in 2023 there were 93 million CTs done on 62 million patients. The total estimated lifetime number of ...

Thanks to budget cuts, many potential insights and treatments needed to propel oncology forward will never be realized.

CHINO HILLS, CALIFORNIA / ACCESS Newswire / May 6, 2025 /SOHM, Inc. (OTC PINK:SHMN), a biotech company at the forefront of precision cellular engineering, announced today the successful development of ...

NuCana plc (NASDAQ: NCNA), a clinical-stage biopharmaceutical company that focuses on significantly improving treatment outcomes for patients with cancer, announced that it has priced a registered ...

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated ...

Castle Biosciences, Inc. ( NASDAQ: CSTL) Q1 2025 Earnings Conference Call May 5, 2025 4:30 PM ET Camilla Zuckero - Vice President of Investor Relations and Corporate Affairs Derek Maetzold - Founder, ...

Results from studies at Virginia Commonwealth University (VCU) show that an Aramchol and Bayer's Regorafenib drug combination significantly reduced hepatic tumor ...

The FDA’s decision to ban dyes and other synthetic substances often rests on the Delaney clause, a 49‑word law from 1958 that ...

Expected to complement Castle's current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and additional technologies in development ...